<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>207(6)</volume><submitter>Munz N</submitter><funding>Swiss National Science Foundation</funding><journal>British journal of haematology</journal><pagination>2550-2552</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12710110</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Polatuzumab vedotin and CD79B: A study of efficacy in R-CHOP-resistant diffuse large B-cell lymphoma.</pubmed_title><pmcid>PMC12710110</pmcid><funding_grant_id>310030</funding_grant_id><funding_grant_id>205601</funding_grant_id><funding_grant_id>197466</funding_grant_id><funding_grant_id>182880</funding_grant_id><funding_grant_id>310030_197466</funding_grant_id><pubmed_authors>Simonetta F</pubmed_authors><pubmed_authors>Arribas AJ</pubmed_authors><pubmed_authors>Bertoni F</pubmed_authors><pubmed_authors>Stussi G</pubmed_authors><pubmed_authors>Bordone Pittau R</pubmed_authors><pubmed_authors>Munz N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Polatuzumab vedotin and CD79B: A study of efficacy in R-CHOP-resistant diffuse large B-cell lymphoma.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-05-26T20:01:52.144Z</modification><creation>2026-05-25T03:12:03.041Z</creation></dates><accession>S-EPMC12710110</accession><cross_references><pubmed>41057281</pubmed><doi>10.1111/bjh.70185</doi></cross_references></HashMap>